Source: Annual Congress 2008 - Outcome and trends in obstructive lung disease (OLD) and cardiovascular relation to OLD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. H. Janner, N. S. Godtfredsen, E. Prescott, P. Lange, J. Vestbo (Copenhagen, Denmark). Is COPD a risk factor for increased arterial stiffness?. Eur Respir J 2008; 32: Suppl. 52, 4175

Member's Comments

No comment yet.

Related content which might interest you: Increased risk of peripheral arterial disease in individuals with COPD Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017 Is COPD a risk factor for diabetes? Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Pulmonary pressure at rest and during slight exercise might have prognostic relevance in patients at risk for pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Effects of pulmonary rehabilitation in COPD patients with increased baseline arterial stiffness: The CIROCO study Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010 COPD is associated with an increased risk of peripheral artery disease and mortality Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018 Year: 2018 Reduced pulmonary function is associated with aortic stiffness in men free of cardiovascular diseases Source: Eur Respir J 2002; 20: Suppl. 38, 516s Year: 2002 The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension. Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Arterial hypertension and the risk of severity and mortality of COVID-19 Source: Eur Respir J, 55 (6) 2001148; 10.1183/13993003.01148-2020 Year: 2020 Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018 Elevated pulmonary vascular resistance is associated with increased risk of death in IPF Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 The study of risk in pulmonary arterial hypertension Source: Eur Respir Rev 2012 21:234-238 Year: 2012 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Tobacco smoke: A risk factor for pulmonary arterial hypertension? A case control study Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation Source: Eur Respir J 2014; 43: 1306-1315 Year: 2014 Prevalence and risk factors of elevated pulmonary artery pressures in adults with sickle cell disease Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010